Loading...
Market
What major complications, if any, will the first patient with BiVACOR® Total Artificial Heart experience by December 31, 2024?
2
Resolution / Starting Odds
Infection • 25%
Device malfunction • 25%
Rejection • 25%
No major complications • 25%
Medical reports and press releases from Texas Heart Institute or Baylor St. Luke's Medical Center.
Story
Texas Heart Institute Implants First BiVACOR® Total Artificial Heart at Baylor St. Luke's
Jul 25, 2024, 04:19 PM
The Texas Heart Institute has successfully implanted the BiVACOR® Total Artificial Heart in a human for the first time. The groundbreaking procedure was performed at Baylor St. Luke's Medical Center in the Texas Medical Center, Houston. The artificial heart, made of titanium and featuring a single moving part that uses magnets to pump blood, was implanted in a local man who otherwise would have died from heart failure. This innovative technology represents a significant advancement in the field of heart transplants, potentially transforming the future of organ transplantation.
View original story
Similar markets
Mechanical failure • 25%
Patient immune response • 25%
Surgical complications • 25%
Other • 25%
Increased patient survival rate • 25%
Improved quality of life • 25%
Reduced need for medication • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
United Kingdom • 25%
Germany • 25%
Japan • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Successful with no complications • 25%
Successful with minor complications • 25%
Successful with major complications • 25%
Unsuccessful • 25%
Yes • 50%
No • 50%